Julia E. Miller
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Julia E. Miller has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Jeanine Peters‐Kennedy
Department of Population Medicine and Diagnostic Sciences Cornell University, College of Veterinary Medicine Ithaca New York USA
2 shared publications - Antonia Fettelschoss-Gabriel
Department of Dermatology University Hospital Zurich Schlieren Switzerland
1 shared publication Bettina Wagner
Department of Population Medicine and Diagnostic Sciences, Cornell University College of Veterinary Medicine, Cornell University, Ithaca, NY, 14853, USA
1 shared publicationChristina Mazulis
Department of Clinical Sciences College of Veterinary Medicine Cornell University Ithaca NY 14853 USA
1 shared publicationCynthia Hopf
Janet L. Swanson Wildlife Hospital Cornell University Ithaca NY 14853 USA
1 shared publicationDanny W. Scott
Department of Clinical Sciences College of Veterinary Medicine Cornell University Ithaca NY 14853 USA
1 shared publication
Latest Publications
- 25 May 2021
- Published by Wiley in Veterinary Dermatology
- Vol. 32 (4) , 389-+
Erythema multiforme complicated by bacterial folliculitis in a 3‐year‐old Nubian goat
Erythema multiforme is a rare hypersensitivity reaction that is reported in several domestic animal species, and not in goats. This case report describes the clinical and histopathological features of erythema multiforme and secondary bacterial skin infection in a goat.
- 25 May 2021
- Published by Wiley in Veterinary Dermatology
- Vol. 32 (4) , 389-+
Erythema multiforme complicated by bacterial folliculitis in a 3‐year‐old Nubian goat
Erythema multiforme is a rare hypersensitivity reaction that is reported in several domestic animal species, and not in goats. This case report describes the clinical and histopathological features of erythema multiforme and secondary bacterial skin infection in a goat.
- 13 November 2020
- Published by Wiley in Veterinary Dermatology
- Vol. 32 (2) , 188-+
Regional alopecia and dermatitis due to Lodderomyces elongisporus in a North American porcupine (Erethizon dorsatum)
Background: Lodderomyces elongisporus is a yeast with a worldwide distribution that has been reported as a cause of infection in immunocompromised humans and in a dog that had been quilled by a porcupine.Objectives: The objective of this report is to describe the clinical presentation, diagnosis and treatment of dermatitis caused by L. elongisporus in a North American porcupine (Erethizon dorsatum).Animal: One wild adult male North American porcupine from New York state, USA.Methods and materials: The porcupine was presented for alopecia and scaling dermatitis over the caudal dorsum. Diagnostic testing included cytological evaluation, trichogram, bacterial and fungal culture, and histopathological examination of skin biopsies.Results: Histopathological findings from skin specimens demonstrated mild eosinophilic perivascular‐to‐interstitial dermatitis with superficial dermal fibrosis, mild epidermal hyperplasia with moderate‐to‐marked intracorneal and intrafollicular yeast. Fungal culture with matrix‐assisted laser desorption/ionization confirmed L. elongisporus as the cause of the dermatitis. The porcupine was treated with a six week course of oral itraconazole with clinical resolution.Clinical relevance: Infection with L. elongisporus should be included as a differential diagnosis for North American porcupines exhibiting signs of dermatitis including scaling and alopecia. This case report may be relevant for the diagnosis and treatment of porcupines with dermatitis and for animals or humans that have been quilled by a porcupine.
- 13 November 2020
- Published by Wiley in Veterinary Dermatology
- Vol. 32 (2) , 188-+
Regional alopecia and dermatitis due to Lodderomyces elongisporus in a North American porcupine (Erethizon dorsatum)
Background: Lodderomyces elongisporus is a yeast with a worldwide distribution that has been reported as a cause of infection in immunocompromised humans and in a dog that had been quilled by a porcupine.Objectives: The objective of this report is to describe the clinical presentation, diagnosis and treatment of dermatitis caused by L. elongisporus in a North American porcupine (Erethizon dorsatum).Animal: One wild adult male North American porcupine from New York state, USA.Methods and materials: The porcupine was presented for alopecia and scaling dermatitis over the caudal dorsum. Diagnostic testing included cytological evaluation, trichogram, bacterial and fungal culture, and histopathological examination of skin biopsies.Results: Histopathological findings from skin specimens demonstrated mild eosinophilic perivascular‐to‐interstitial dermatitis with superficial dermal fibrosis, mild epidermal hyperplasia with moderate‐to‐marked intracorneal and intrafollicular yeast. Fungal culture with matrix‐assisted laser desorption/ionization confirmed L. elongisporus as the cause of the dermatitis. The porcupine was treated with a six week course of oral itraconazole with clinical resolution.Clinical relevance: Infection with L. elongisporus should be included as a differential diagnosis for North American porcupines exhibiting signs of dermatitis including scaling and alopecia. This case report may be relevant for the diagnosis and treatment of porcupines with dermatitis and for animals or humans that have been quilled by a porcupine.
- 22 August 2019
- Published by Wiley in Veterinary Dermatology
- Vol. 30 (6) , 536-+
Comparison of three clinical scoring systems for Culicoides hypersensitivity in a herd of Icelandic horses
Background: Culicoides hypersensitivity (CH), an intensely pruritic and seasonal allergic dermatitis, is a common allergic disease affecting horses worldwide. Currently, there is no validated clinical scoring system for the quantification of clinical signs associated with CH.Objectives: To (i) determine the best cut‐off point of three scoring systems, (ii) test the accuracy of each system when compared to the clinical diagnosis of an experienced veterinarian and (iii) assess agreement between systems.Animals: Icelandic horses (n = 20); eight with CH and 12 unaffected, from a research herd receiving no treatments for allergic dermatitis.Methods and materials: Lesion scores were recorded biweekly from April until September with three clinical scoring systems (A, B and C) by a single observer initially blinded to CH status. Separate logistic regression analyses for each time point were used to determine appropriate cut‐offs for CH classification. Spearman's rho and Cohen's kappa were calculated to analyze correlation of scores and agreement of CH categorization between systems, respectively.Results: The best allergic cut‐off scores for system A, B and C were determined to be three, eight and 12, respectively. For each system median areas under the curve (>0.85) were excellent and discriminatory ability for correctly classifying CH status was strong. Excellent correlation between scores for each system (Spearman's rho > 0.96) and excellent intersystem agreement for CH categorization (kappa ≥ 0.73) were found across scoring time points.Conclusion and clinical importance: Results support the use of these scoring systems as templates for the future standardization of a CH clinical scoring system.
- 22 August 2019
- Published by Wiley in Veterinary Dermatology
- Vol. 30 (6) , 536-+
Comparison of three clinical scoring systems for Culicoides hypersensitivity in a herd of Icelandic horses
Background: Culicoides hypersensitivity (CH), an intensely pruritic and seasonal allergic dermatitis, is a common allergic disease affecting horses worldwide. Currently, there is no validated clinical scoring system for the quantification of clinical signs associated with CH.Objectives: To (i) determine the best cut‐off point of three scoring systems, (ii) test the accuracy of each system when compared to the clinical diagnosis of an experienced veterinarian and (iii) assess agreement between systems.Animals: Icelandic horses (n = 20); eight with CH and 12 unaffected, from a research herd receiving no treatments for allergic dermatitis.Methods and materials: Lesion scores were recorded biweekly from April until September with three clinical scoring systems (A, B and C) by a single observer initially blinded to CH status. Separate logistic regression analyses for each time point were used to determine appropriate cut‐offs for CH classification. Spearman's rho and Cohen's kappa were calculated to analyze correlation of scores and agreement of CH categorization between systems, respectively.Results: The best allergic cut‐off scores for system A, B and C were determined to be three, eight and 12, respectively. For each system median areas under the curve (>0.85) were excellent and discriminatory ability for correctly classifying CH status was strong. Excellent correlation between scores for each system (Spearman's rho > 0.96) and excellent intersystem agreement for CH categorization (kappa ≥ 0.73) were found across scoring time points.Conclusion and clinical importance: Results support the use of these scoring systems as templates for the future standardization of a CH clinical scoring system.